Kreido’s STT® Reactor System to Be Utilized by Huntsman
News Oct 07, 2005
Kreido Laboratories has announced that Huntsman has purchased its STT® Reactor System.
Kreido Laboratories has pioneered a system for the manufacturing of chemicals, pharmaceuticals and other biological products.
The STT® system is designed to improve selectivity, increase yields and initiate chemistries.
The technology improves the efficiency, quality and speed of many chemical processes and facilitates continuous manufacturing.
The Huntsman transaction represents Kreido™s entry into the European marketplace.
Kreido has successfully applied the STT® Reactor System to the manufacturing of chemicals.
“We believe Huntsman will greatly benefit from our technology, as the systems ability to mitigate mass transfer limitations and accelerate reactions is well known,” said Kreido Laboratories Managing Director Ben Binninger.
“Numerous STT® Reactor Systems are already operating in the United States, and we are certainly delighted to expand our reach into Europe.”
Lab Innovations 2018 – Registration Opens and Keynotes AnnouncedNews
Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.READ MORE
BioAscent Secures Investment to Expand its Integrated Drug Discovery ServicesNews
£1.6m investment recognises BioAscent’s unique capabilities.READ MORE